Weill Cornell startup offers personalized, effective treatment for obesity

Katherine H. Saunders MD ’11, an assistant professor of clinical medicine at Weill Cornell Medicine, specializes in the care of patients with obesity and weight-related medical complications.

Around Cornell

$9M grant funds study of gut-brain connection in Parkinson’s

The grant will fund an effort to study how abnormal protein aggregates may spread from the gut to the brain to drive the early stages of Parkinson’s disease.

Partnering with traditional healers boosts HIV testing in Uganda

Partnering with traditional healers improves uptake of HIV tests in rural Uganda, according to a trial by Weill Cornell Medicine and Mbarara University of Science and Technology investigators.

A.D. White professors named; fall visit announced

Two renowned biologists, May Berenbaum, Ph.D. ’80, and Ellen Rothenberg, have been appointed to six-year terms as Andrew Dickson White Professors-at-Large.

Scientists uncover key vulnerability of aggressive lymphomas

Researchers found that they could use an existing experimental drug to slow metabolism of certain aggressive B-cell lymphomas in lab-dish and animal studies.

Bacteria underlie success of fecal microbiota transplants

Researchers from Weill Cornell Medicine sampled gut bacteria from healthy fecal microbiota transplantation donors and from recipients with ulcerative colitis, identifying the bacterial strains that correlates with effective treatment.

Discovery may help explain sex differences in binge drinking

A brain circuit that works as a brake on binge alcohol drinking may explain why women may be more vulnerable to alcohol-use disorders, a Weill Cornell Medicine study found.

Koretzky named president of American Association of Immunologists

During his term as president of the American Association of Immunologists, Dr. Gary Koretzky '78, vice provost for academic integration at Cornell, aims to improve science advocacy, public outreach and more.

Around Cornell

COVID may trigger hyperglycemia by harming fat cells

According to a new study from researchers at Weill Cornell, COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia.